Back to Search
HERBERT MELTZER, MD
MD
Pain Medicine (Anesthesiology) Physician
NPI: 1538268966Individual
Specialties, Licenses & Credentials
Pain Medicine (Anesthesiology) PhysicianPrimary
Anesthesiology — Pain Medicine
Code: 207LP2900X
MD27552(TN)
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia.
PMID 31706786·Schizophr Res·2020
2-rct
Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorder.
PMID 18823757·Schizophr Res·2008
4-observational
In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
PMID 18772033·Prog Brain Res·2008
6-review
Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?
PMID 18707769·Behav Brain Res·2008
6-review
Efficacy and tolerability of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 6-week, placebo-controlled studies.
PMID 18466043·J Clin Psychiatry·2008
2-rct
A randomized, double-blind comparison of clozapine and high-dose olanzapine in treatment-resistant patients with schizophrenia.
PMID 18232726·J Clin Psychiatry·2008
4-observational
Illuminating the molecular basis for some antipsychotic drug-induced metabolic burden.
PMID 17360600·Proc Natl Acad Sci U S A·2007
8-other
Interpreting the efficacy findings in the CATIE study: what clinicians should know.
PMID 16816796·CNS Spectr·2006
8-other
Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine.
PMID 15816797·J Clin Psychiatry·2005
6-review
Cognitive factors in schizophrenia: causes, impact, and treatment.
PMID 15475873·CNS Spectr·2004
8-other
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder.
PMID 15169685·Am J Psychiatry·2004
3-trial
Beyond control of acute exacerbation: enhancing affective and cognitive outcomes.
PMID 14978453·CNS Spectr·2003
4-observational
Serotonin receptors: their key role in drugs to treat schizophrenia.
PMID 14642974·Prog Neuropsychopharmacol Biol Psychiatry·2003
6-review
Reducing the risk for suicide in schizophrenia and affective disorders.
PMID 14628990·J Clin Psychiatry·2003
4-observational
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
PMID 12511175·Arch Gen Psychiatry·2003
3-trial
Clozapine-induced weight gain predicts improvement in psychopathology.
PMID 12413638·Schizophr Res·2003
3-trial
Commentary on "clinical studies on the mechanism of action of clozapine; the dopamine-serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18-S27.
PMID 12185394·Psychopharmacology (Berl)·2002
8-other
Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options.
PMID 12126596·Curr Psychiatry Rep·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3601 TVC
NASHVILLE, TN 37232 - Phone
- (615) 322-3000
Quick Facts
- NPI
- 1538268966
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile